| Bid | n/a |
| Market Cap | 4.35M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.11 |
| PE Ratio (ttm) | -0.78 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | n/a |
| Volume | 664 |
| Avg. Volume (20D) | 3,405 |
| Open | 3.22 |
| Previous Close | undefined |
| Day's Range | 3.22 - 3.22 |
| 52-Week Range | 3.04 - 18.00 |
| Beta | undefined |
About GHSI
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as wel...
Analyst Forecast
According to 1 analyst ratings, the average rating for GHSI stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
3 years ago · investorplace.com
GHSI Stock: 12 Things to Know About Guardion Health Science as Shares RocketGuardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading. The post GHSI Stock: 12 Things to Know About Guardion Health Science as S...
4 years ago · investorplace.com
GHSI Stock: 11 Things for Investors to Know About Guardion Health SciencesGuardion Health Sciences (GHSI) is seeing a massive spike in its stock on Wednesday despite a lack of news concerning the company. The post GHSI Stock: 11 Things for Investors to Know About Guardion H...
